Legal Marijuana Segmentation
The legal marijuana market is segmented by application into chronic pain, cancer, mental disorders, glaucoma and others. Among these segments, the chronic pain segment is anticipated to record the largest market share over the forecast period owing to the presence of chemical compounds, such as cannabinoids, which helps in relieving severe pain. Furthermore, the cannabinoids have the properties of altering pain perception pathways in our brain, which helps in reducing severe pain.
Our in-depth analysis of the global legal marijuana market includes the following segments
|
By Form |
|
|
By Usage Type |
|
|
By Distribution Channel |
|
|
By Application |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of legal marijuana is estimated at USD 31.83 billion.
Legal Marijuana Market size was over USD 26.18 billion in 2024 and is anticipated to cross USD 496.41 billion by 2037, witnessing more than 25.4% CAGR during the forecast period i.e., between 2025-2037.
North America industry is predicted to dominate majority revenue share by 2037, attributed to increasing legalization of marijuana in the region for usage in pharmaceutical sector.
The major players in the market are Organigram Holdings Inc., CannTrust Ltd., HEXO Corp., The Cronos Group, Aphria Inc., Terra Tech Corp., Aurora Cannabis Inc., Canopy Growth Corporation, Tilray, and others.
